A Phase I/Randomized Phase II Study of MLN0128 vs. Pazopanib in Patients with Locally Advanced/Unresectable and/or Metastatic Sarcoma

Type of Cancer
Skin and Soft Tissue

Site
Hackensack

Sponsor
Alliance

Protocol Number
A091304

To Learn More Call
201-510-0910